Miromatrix Medical Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
72
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$140M
- Investors
-
1
Miromatrix Medical General Information
Description
Developer of fully biological replacement organs designed to eliminate limitations associated with the organ transplant waiting list. The company products include an external liver assist product and have fully implantable bioengineered liver intended to treat patients with acute and chronic liver failure, miroheart, mirolung, and miro pancreas, enabling businesses to provide better transplantation techniques and equipment.
Contact Information
Website
www.miromatrix.comCorporate Office
- 6455 Flying Cloud Drive
- Eden Prairie, MN 55344
- United States
Corporate Office
- 6455 Flying Cloud Drive
- Eden Prairie, MN 55344
- United States
Miromatrix Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Merger/Acquisition | 29-Oct-2023 | $140M | Completed | Generating Revenue | ||
| 14. IPO | 24-Jun-2021 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series C) | 28-May-2021 | Completed | Profitable | |||
| 12. Debt - PPP | 06-Apr-2020 | Completed | Profitable | |||
| 11. Later Stage VC | 06-Mar-2020 | Completed | Profitable | |||
| 10. Grant | 16-Oct-2019 | Completed | Profitable | |||
| 9. Grant | 17-Sep-2019 | Completed | Profitable | |||
| 8. Later Stage VC (Series B2) | 11-Jul-2018 | Completed | Profitable | |||
| 7. Accelerator/Incubator | $29.1M | Completed | Profitable | |||
| 6. Later Stage VC (Series B) | 04-Nov-2015 | $23.8M | $29.1M | Completed | Profitable |
Miromatrix Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B2 | ||||||||
| Series B | 4,000,000 | $0.000010 | ||||||
| Series A | 3,300,000 | $0.000010 | $2.5 | $2.5 | 1x | $2.5 | 7.73% |
Miromatrix Medical Comparisons
Industry
Financing
Details
Miromatrix Medical Competitors (17)
One of Miromatrix Medical’s 17 competitors is Aspect Biosystems, a Venture Capital-Backed company based in Vancouver, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| InSphero | Private Equity-Backed | Schlieren, Switzerland | ||||
| Videregen | Venture Capital-Backed | Leeds, United Kingdom | ||||
| Arrowhead Pharmaceuticals | Corporation | Pasadena, CA |
Miromatrix Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Miromatrix Medical Patents
Miromatrix Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024310809-A1 | Manufacturing of bioengineered recellularized organs and methods of use thereof | Pending | 30-Jun-2023 | ||
| EP-4735066-A1 | Manufacturing of bioengineered recellularized organs and methods of use thereof | Pending | 30-Jun-2023 | ||
| US-20250002862-A1 | Manufacturing of bioengineered recellularized organs and methods of use thereof | Pending | 30-Jun-2023 | ||
| WO-2025007047-A1 | Manufacturing of bioengineered recellularized organs and methods of use thereof | Inactive | 30-Jun-2023 | ||
| AU-2024281234-A1 | Methods and uses of differentiated cells | Pending | 01-Jun-2023 | C12N5/0686 |
Miromatrix Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Miromatrix Medical Former Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Baxter International | Corporation | Minority | ||
| Brightstone Venture Capital | Venture Capital | Minority | ||
| CareDx | Corporation | Minority | ||
| Cheshire MD Holdings | Holding Company | Minority | ||
| DaVita Venture Group | Corporate Venture Capital | Minority |
Miromatrix Medical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Miromatrix Medical FAQs
-
When was Miromatrix Medical founded?
Miromatrix Medical was founded in 2009.
-
Where is Miromatrix Medical headquartered?
Miromatrix Medical is headquartered in Eden Prairie, MN.
-
What is the size of Miromatrix Medical?
Miromatrix Medical has 72 total employees.
-
What industry is Miromatrix Medical in?
Miromatrix Medical’s primary industry is Biotechnology.
-
Is Miromatrix Medical a private or public company?
Miromatrix Medical is a Private company.
-
What is the current valuation of Miromatrix Medical?
The current valuation of Miromatrix Medical is .
-
What is Miromatrix Medical’s current revenue?
The current revenue for Miromatrix Medical is .
-
How much funding has Miromatrix Medical raised over time?
Miromatrix Medical has raised $114M.
-
Who are Miromatrix Medical’s investors?
Baxter International, Brightstone Venture Capital, CareDx, Cheshire MD Holdings, and DaVita Venture Group are 5 of 18 investors who have invested in Miromatrix Medical.
-
Who are Miromatrix Medical’s competitors?
Aspect Biosystems, Centrexion Therapeutics, InSphero, Videregen, and Arrowhead Pharmaceuticals are some of the 17 competitors of Miromatrix Medical.
-
When was Miromatrix Medical acquired?
Miromatrix Medical was acquired on 29-Oct-2023.
-
Who acquired Miromatrix Medical?
Miromatrix Medical was acquired by United Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
